Print

UKHVCSpoke003

Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses (UKHVCSpoke003)

Trial Details:

I Completed
Imperial College London, Wellcome Trust, Medical Research Council June 24, 2013
DNA - CN54ENV and ZM96GPN,CN54gp140,MVA-C DNA gag-pol-nef 96ZM651-8 and one gp140 env clade C 97CN54 ; MVA gag-pol-nef and gp120 env clade-C 97CN54; Protein Env C CN54gp140
DNA - CN54ENV and ZM96GPN DNA
MVA-C Viral Vector - Pox
CN54gp140 Protein
United Kingdom 40
NCT01922284
http://www.clinicaltrials.gov/ct2/show/NCT01922284?term=hiv+and+vaccine&lup_s=08%2F11%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14